chevron_leftBack
As of 20 June 2026, Parmax Pharma Ltd. has a market cap of $1.23M USD, ranking #48228 globally and #4936 in India.
It ranks #4281 in the Healthcare sector, and #1351 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.23MUSD
115.98M INR
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Umang Gosalia
open_in_new
Founded
1994
Website
parmaxpharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -5.6% | 23% | -8.4% | -11% | -31% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
540359
(PARMAX)
Parmax Pharma Ltd
ISIN: INE240T01014
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
31.00 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Parmax Pharma Ltd.
Parmax Pharma Limited operates in the pharmaceutical business in India. It manufactures and sells bulk drugs, drug intermediates, and specialty chemicals. The company was incorporated in 1994 and is based in Rajkot, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
4M%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
1M%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
1M%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
955K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
803K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
790K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
62M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
45M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
29M%
|
97.4
|
|
SIX: RO
|
$318.3B
26M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
23M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
22M%
|
15.1
|
chevron_leftBack